Financhill
Sell
40

DELL Quote, Financials, Valuation and Earnings

Last price:
$115.78
Seasonality move :
3.61%
Day range:
$110.17 - $116.46
52-week range:
$74.32 - $179.70
Dividend yield:
1.47%
P/E ratio:
20.27x
P/S ratio:
0.89x
P/B ratio:
--
Volume:
11.9M
Avg. volume:
8.8M
1-year change:
59.86%
Market cap:
$81.1B
Revenue:
$88.4B
EPS (TTM):
$5.71
Period Ending 2020-01-31 2021-01-31 2022-01-31 2023-01-31 2024-01-31
Revenue $84.8B $86.7B $101.2B $102.3B $88.4B
Revenue Growth (YoY) -6.41% 2.19% 16.76% 1.09% -13.56%
 
Cost of Revenues $64.2B $66.5B $79.3B $79.6B $67.6B
Gross Profit $20.6B $20.1B $21.9B $22.7B $20.9B
Gross Profit Margin 24.33% 23.24% 21.63% 22.18% 23.6%
 
R&D Expenses $2.5B $2.5B $2.6B $2.8B $2.8B
Selling, General & Admin $15.8B $14B $14.7B $14.1B $12.9B
Other Inc / (Exp) -$120M $565M $2.7B -$1.4B -$84M
Operating Expenses $18.3B $16.5B $17.2B $16.9B $15.7B
Operating Income $2.4B $3.7B $4.7B $5.8B $5.2B
 
Net Interest Expenses $2.3B $1.9B $1.5B $1.2B $1.2B
EBT. Incl. Unusual Items -$51M $2.3B $5.9B $3.2B $3.9B
Earnings of Discontinued Ops. $5B $1.3B $765M -- --
Income Tax Expense -$572M $101M $981M $803M $692M
Net Income to Company $5.5B $3.5B $5.7B $2.4B $3.2B
 
Minority Interest in Earnings -$913M -$255M -$144M $20M $16M
Net Income to Common Excl Extra Items $4.6B $3.3B $5.6B $2.4B $3.2B
 
Basic EPS (Cont. Ops) $6.38 $4.37 $7.02 $3.24 $4.36
Diluted EPS (Cont. Ops) $6.03 $4.22 $7.02 $3.24 $4.36
Weighted Average Basic Share $724M $744M $762M $734M $720M
Weighted Average Diluted Share $751M $767M $791M $753M $736M
 
EBITDA $8.5B $9.8B $12B $7.7B $8.7B
EBIT $2.3B $4.4B $7.5B $4.5B $5.4B
 
Revenue (Reported) $84.8B $86.7B $101.2B $102.3B $88.4B
Operating Income (Reported) $2.4B $3.7B $4.7B $5.8B $5.2B
Operating Income (Adjusted) $2.3B $4.4B $7.5B $4.5B $5.4B
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Revenue $23.5B $26.4B $24.7B $22.3B $24.4B
Revenue Growth (YoY) 2.79% 12.53% -6.45% -9.99% 9.51%
 
Cost of Revenues $16.2B $20.9B $19B $17.1B $19.1B
Gross Profit $7.3B $5.5B $5.7B $5.1B $5.3B
Gross Profit Margin 30.92% 20.94% 23.09% 23.14% 21.78%
 
R&D Expenses $1.4B $650M $677M $692M $745M
Selling, General & Admin $4.8B $3.8B $3.3B $3B $2.9B
Other Inc / (Exp) $796M $4B -$1B -$22M $17M
Operating Expenses $6.1B $4.5B $3.9B $3.7B $3.6B
Operating Income $1.1B $1B $1.8B $1.5B $1.7B
 
Net Interest Expenses $523M $452M $280M $284M $293M
EBT. Incl. Unusual Items $1.4B $4.5B $454M $1.2B $1.4B
Earnings of Discontinued Ops. -- $205M -- -- --
Income Tax Expense $521M $864M $213M $176M $265M
Net Income to Company $881M $3.9B $241M $1B $1.1B
 
Minority Interest in Earnings -$49M -$45M $4M $2M $5M
Net Income to Common Excl Extra Items $832M $3.8B $245M $1B $1.1B
 
Basic EPS (Cont. Ops) $1.11 $5.02 $0.34 $1.39 $1.61
Diluted EPS (Cont. Ops) $1.08 $4.87 $0.33 $1.36 $1.58
Weighted Average Basic Share $747M $766M $728M $722M $703M
Weighted Average Diluted Share $771M $788M $743M $740M $717M
 
EBITDA $3.3B $6.3B $1.6B $2.4B $2.5B
EBIT $2B $5B $755M $1.6B $1.7B
 
Revenue (Reported) $23.5B $26.4B $24.7B $22.3B $24.4B
Operating Income (Reported) $1.1B $1B $1.8B $1.5B $1.7B
Operating Income (Adjusted) $2B $5B $755M $1.6B $1.7B
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Revenue $84.8B $91.8B $105.3B $91.1B $94B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $64.1B $76.6B $82.7B $69.8B $73.2B
Gross Profit $20.7B $15.1B $22.5B $21.3B $20.7B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $2.7B $537M $2.6B $2.9B $3B
Selling, General & Admin $14.6B $10.8B $13.8B $13.5B $12.3B
Other Inc / (Exp) $642M $3.8B -$2.9B -$104M $20M
Operating Expenses $17.2B $11.4B $16.4B $16.4B $15.3B
Operating Income $3.4B $3.8B $6.2B $4.9B $5.4B
 
Net Interest Expenses $2B $1.3B $1.1B $1.3B $1.2B
EBT. Incl. Unusual Items $2.1B $6.3B $2.3B $3.5B $4.2B
Earnings of Discontinued Ops. -- $735M $30M -- --
Income Tax Expense $4.5B $1.2B $467M $879M $135M
Net Income to Company $2.6B $7B $1.8B $2.6B $4.1B
 
Minority Interest in Earnings -$147M -$261M $13M $22M $17M
Net Income to Common Excl Extra Items $2.4B $6.8B $1.8B $2.7B $4.1B
 
Basic EPS (Cont. Ops) $3.27 $8.92 $2.45 $3.70 $5.80
Diluted EPS (Cont. Ops) $3.18 $8.62 $2.38 $3.62 $5.71
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $9.8B $12.8B $6.5B $8.4B $8.9B
EBIT $4.2B $7.8B $3.4B $5.1B $5.7B
 
Revenue (Reported) $84.8B $91.8B $105.3B $91.1B $94B
Operating Income (Reported) $3.4B $3.8B $6.2B $4.9B $5.4B
Operating Income (Adjusted) $4.2B $7.8B $3.4B $5.1B $5.7B
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Revenue $68.1B $73.2B $77.3B $66.1B $71.6B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $46.8B $56.9B $60.3B $50.6B $56.2B
Gross Profit $21.3B $16.3B $16.9B $15.6B $15.4B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $3.9B $2B $2B $2.1B $2.3B
Selling, General & Admin $14.4B $11.3B $10.4B $9.7B $9.2B
Other Inc / (Exp) $799M $4.2B -$1.4B -$163M -$59M
Operating Expenses $18.3B $13.2B $12.3B $11.8B $11.5B
Operating Income $3B $3.1B $4.6B $3.7B $3.9B
 
Net Interest Expenses $1.7B $1.3B $856M $958M $943M
EBT. Incl. Unusual Items $2B $6B $2.3B $2.6B $2.9B
Earnings of Discontinued Ops. -- $735M -- -- --
Income Tax Expense -$124M $1B $486M $562M $5M
Net Income to Company $2.2B $5.7B $1.8B $2B $2.9B
 
Minority Interest in Earnings -$139M -$145M $12M $14M $15M
Net Income to Common Excl Extra Items $2B $5.6B $1.8B $2.1B $2.9B
 
Basic EPS (Cont. Ops) $2.71 $7.28 $2.45 $2.84 $4.16
Diluted EPS (Cont. Ops) $2.64 $7.05 $2.38 $2.78 $4.07
Weighted Average Basic Share $2.2B $2.3B $2.2B $2.2B $2.1B
Weighted Average Diluted Share $2.3B $2.4B $2.3B $2.2B $2.2B
 
EBITDA $7.9B $11B $5.5B $6.3B $6.4B
EBIT $3.9B $7.3B $3.2B $3.8B $4B
 
Revenue (Reported) $68.1B $73.2B $77.3B $66.1B $71.6B
Operating Income (Reported) $3B $3.1B $4.6B $3.7B $3.9B
Operating Income (Adjusted) $3.9B $7.3B $3.2B $3.8B $4B
Period Ending 2020-01-31 2021-01-31 2022-01-31 2023-01-31 2024-01-31
Cash and Equivalents $9.3B $9.5B $9.5B $8.6B $7.4B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $12.5B $10.7B $12.9B $12.5B $9.3B
Inventory $3.3B $3.4B $5.9B $4.8B $3.6B
Prepaid Expenses -- -- -- -- --
Other Current Assets $6.9B $9.8B $11.5B $10.8B $11B
Total Current Assets $36.9B $43.6B $45B $42.4B $35.9B
 
Property Plant And Equipment $7.8B $4.8B $5.4B $6.2B $6.4B
Long-Term Investments $864M $1.3B $1.8B $1.5B $1.3B
Goodwill $41.7B $20B $19.8B $19.7B $19.7B
Other Intangibles $18.1B $9.1B $7.5B $6.5B $5.7B
Other Long-Term Assets $1.7B $38.7B $7B $7.3B $7.1B
Total Assets $118.9B $123.4B $92.7B $89.6B $82.1B
 
Accounts Payable $20.1B $21.6B $27.1B $18.6B $19.4B
Accrued Expenses $1.7B $7.2B $7.6B $8.9B $6.8B
Current Portion Of Long-Term Debt $7.7B -- -- -- --
Current Portion Of Capital Lease Obligations $432M -- -- -- --
Other Current Liabilities $2.1B $4.4B -- -- --
Total Current Liabilities $52.5B $54.1B $56.2B $51.7B $48.5B
 
Long-Term Debt $44.3B $32.9B $21.1B $23B $19B
Capital Leases -- -- -- -- --
Total Liabilities $115.1B $115.4B $94.3B $92.6B $84.4B
 
Common Stock $16.1B $16.8B $7.9B $8.4B $8.9B
Other Common Equity Adj -$709M -$314M -$431M -$1B -$800M
Common Equity -$945M $3B -$1.7B -$3.1B -$2.4B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $4.7B $5.1B $105M $97M $95M
Total Equity $3.8B $8B -$1.6B -$3B -$2.3B
 
Total Liabilities and Equity $118.9B $123.4B $92.7B $89.6B $82.1B
Cash and Short Terms $9.3B $9.5B $9.5B $8.6B $7.4B
Total Debt $52.1B $39.2B $27B $29.6B $26B
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Cash and Equivalents $11.3B $22.4B $4.9B $8.3B $5.2B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $11.4B $14.2B $11.4B $9.7B $11.2B
Inventory $3.4B $5.4B $6.2B $3.4B $6.7B
Prepaid Expenses -- -- -- -- --
Other Current Assets $7.7B $9.3B $8.3B $5B $9.3B
Total Current Assets $38.6B $57.2B $38.8B $37B $38B
 
Property Plant And Equipment $8.5B $8.9B $6.6B $6.9B $6.3B
Long-Term Investments $1.7B $1.8B $1.5B $1.3B $1.3B
Goodwill $40.6B $40.7B $19.4B $19.6B $19.2B
Other Intangibles $15.3B $12.3B $6.7B $5.9B $5.1B
Other Long-Term Assets $1.7B $1.9B $3.9B $4.3B $6B
Total Assets $118.9B $135.7B $85.2B $83.3B $82B
 
Accounts Payable $19.8B $26.8B $22.5B $19.5B $23.4B
Accrued Expenses $8.7B $9.6B -- -- $6.5B
Current Portion Of Long-Term Debt -- $16.3B $6.8B $6.5B --
Current Portion Of Capital Lease Obligations -- $439M $247M $246M --
Other Current Liabilities -- -- $7.7B $6.2B $211M
Total Current Liabilities $50.3B $69.7B $52B $48.9B $49.5B
 
Long-Term Debt $43.3B $31.7B $20.6B $20.1B $19.4B
Capital Leases -- -- -- -- --
Total Liabilities $112.5B $121.5B $88.5B $85.8B $84.1B
 
Common Stock $16.7B $17.8B $8.2B $8.7B $9B
Other Common Equity Adj -$553M -$394M -$920M -$823M -$820M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $5.1B $5.2B $101M $94M $95M
Total Equity $6.5B $14.2B -$3.4B -$2.6B -$2.2B
 
Total Liabilities and Equity $118.9B $135.7B $85.2B $83.3B $82B
Cash and Short Terms $11.3B $22.4B $4.9B $8.3B $5.2B
Total Debt $49.9B $48B $27.3B $26.6B $25B
Period Ending 2020-01-31 2021-01-31 2022-01-31 2023-01-31 2024-01-31
Net Income to Stockholders $5.5B $3.5B $5.7B $2.4B $3.2B
Depreciation & Amoritzation $6.1B $5.4B $4.6B $3.2B $3.3B
Stock-Based Compensation $1.3B $1.6B $1.6B $931M $878M
Change in Accounts Receivable -$1.6B -$1.1B -$2.4B -$348M $3.3B
Change in Inventories $311M -$243M -$2.5B $875M $975M
Cash From Operations $9.3B $11.4B $10.3B $3.6B $8.7B
 
Capital Expenditures $2.6B $2.1B $2.8B $3B $2.8B
Cash Acquisitions -$2.5B $1.8B $3.9B -$70M -$126M
Cash From Investing -$4.7B -$460M $1.3B -$3B -$2.8B
 
Dividends Paid (Ex Special Dividend) -- -- -- -$964M -$1.1B
Special Dividend Paid
Long-Term Debt Issued $20.5B $16.4B $20.4B $12.5B $7.8B
Long-Term Debt Repaid -$22.1B -$20.9B -$26.7B -$9.8B -$11.2B
Repurchase of Common Stock -$3.6B -$1.6B -$1.8B -$3.3B -$2.5B
Other Financing Activities -$71M -$270M -$8.8B -$39M -$109M
Cash From Financing -$4.6B -$6B -$16.6B -$1.6B -$7.1B
 
Beginning Cash (CF) $10.2B $10.2B $15.2B $10.1B $8.9B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1M $5B -$5B -$1.1B -$1.2B
Ending Cash (CF) $10.2B $15.2B $10.1B $8.9B $7.5B
 
Levered Free Cash Flow $6.7B $9.3B $7.5B $562M $5.9B
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Net Income to Stockholders $881M $3.9B $241M $1B $1.1B
Depreciation & Amoritzation $1.4B $1.2B $832M $822M $765M
Stock-Based Compensation $436M $472M $235M $227M $198M
Change in Accounts Receivable $151M -$1.3B $1.4B $1.1B $405M
Change in Inventories $164M -$1.3B -$372M $153M -$805M
Cash From Operations $3B $3.3B $396M $2.2B $1.6B
 
Capital Expenditures $480M $799M $747M $704M $639M
Cash Acquisitions $2B $4B -- -$127M --
Cash From Investing $1.4B $3.2B -$730M -$825M -$524M
 
Dividends Paid (Ex Special Dividend) -- -- -$238M -$266M -$312M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $2.9B $9.1B $2.3B $2.2B $3.7B
Long-Term Debt Repaid -$7B -$4.6B -$1.8B -$2.7B -$3.2B
Repurchase of Common Stock -$299M -$214M -$622M -$744M -$454M
Other Financing Activities -$80M -$99M -$3M -$5M -$29M
Cash From Financing -$4.3B $4.3B -$386M -$1.4B -$315M
 
Beginning Cash (CF) $12.1B $12.6B $6.1B $8.7B $4.7B
Foreign Exchange Rate Adjustment -$15M -$33M -$149M -$83M $19M
Additions / Reductions $119M $10.8B -$720M -$119M $714M
Ending Cash (CF) $12.2B $23.4B $5.2B $8.4B $5.4B
 
Levered Free Cash Flow $2.5B $2.5B -$351M $1.4B $914M
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Net Income to Stockholders $2.6B $7B $1.8B $2.6B $4.1B
Depreciation & Amoritzation $5.6B $5.1B $3.1B $3.3B $3.2B
Stock-Based Compensation $1.6B $1.8B $919M $903M $802M
Change in Accounts Receivable -$1.6B -$2.7B -$564M $2.1B -$2.1B
Change in Inventories -$251M -$2.1B -$936M $2.6B -$3.6B
Cash From Operations $9B $13.1B $3.9B $9.9B $5.5B
 
Capital Expenditures $2.3B $2.6B $3B $2.8B $2.6B
Cash Acquisitions $1.8B $3.9B -- -$197M $1M
Cash From Investing -$678M $1.6B -$3B -$2.9B -$2.2B
 
Dividends Paid (Ex Special Dividend) -- -- -$728M -$1B -$1.2B
Special Dividend Paid
Long-Term Debt Issued $17.6B $14.7B $16.2B $10.6B $9.5B
Long-Term Debt Repaid -$20.4B -$16.7B -$21.7B -$11.5B -$11.1B
Repurchase of Common Stock -$3B -$1.7B -$3.7B -$1.7B -$3.3B
Other Financing Activities -$274M -$113M -$8.7B -$76M -$121M
Cash From Financing -$5.5B -$3.5B -$18.7B -$3.8B -$6.2B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $2.9B $11.2B -$17.8B $3.2B -$3B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $6.8B $10.5B $960M $7.1B $2.8B
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Net Income to Stockholders $2.2B $5.7B $1.8B $2B $2.9B
Depreciation & Amoritzation $4B $3.7B $2.3B $2.5B $2.3B
Stock-Based Compensation $1.2B $1.4B $703M $675M $599M
Change in Accounts Receivable $261M -$1.4B $517M $3B -$2.5B
Change in Inventories -$198M -$2.1B -$485M $1.2B -$3.3B
Cash From Operations $5.5B $7.2B $851M $7.1B $3.9B
 
Capital Expenditures $1.6B $2.1B $2.2B $2B $1.9B
Cash Acquisitions $1.8B $3.9B -- -$127M --
Cash From Investing $26M $2.1B -$2.2B -$2.1B -$1.5B
 
Dividends Paid (Ex Special Dividend) -- -- -$728M -$811M -$964M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $14.8B $13B $8.8B $6.9B $8.6B
Long-Term Debt Repaid -$17.2B -$13.1B -$8.1B -$9.8B -$9.6B
Repurchase of Common Stock -$1.1B -$1.2B -$3.1B -$1.6B -$2.4B
Other Financing Activities -$270M -$113M -$17M -$54M -$66M
Cash From Financing -$3.5B -$1B -$3.1B -$5.3B -$4.4B
 
Beginning Cash (CF) $35.2B $43.1B $23.5B $25.5B $18.1B
Foreign Exchange Rate Adjustment -$67M -$54M -$343M -$200M -$78M
Additions / Reductions $2.1B $8.2B -$4.5B -$246M -$2B
Ending Cash (CF) $37.2B $51.3B $18.6B $25B $16B
 
Levered Free Cash Flow $3.9B $5.2B -$1.4B $5.1B $2B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 9.73% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 13.45% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 2.28% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock